바로가기메뉴

본문 바로가기 주메뉴 바로가기

A Case of Mycobacterium abscessus Lung Disease in a Patient with H1N1 Influenza Pneumonia

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2010, v.69 no.3, pp.207-211









  • Downloaded
  • Viewed

Abstract

Novel influenza A (H1N1) virus is a common pathogen of febrile respiratory infection recently. Here, we report the case of a 63-year-old male patient who presented with 3 days’ ongoing cough and fever. He was diagnosed with novel influenza A (H1N1) pneumonia by real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR). During treatment for novel influenza A (H1N1), his symptoms and radiologic findings improved initially, but multiple lung nodules developed subsequently and found on chest x-ray (on the 5th hospital day). Mycobacterium abscessus was isolated repeatedly from sputum and bronchoalveolar lavage fluid. To our knowledge, this is the first reported case of Mycobacterium abscessus lung disease in a patient with H1N1 influenza pneumonia.

keywords
Influenza A Virus, H1N1 Subtype, Mycobacterium abscessus, Mycobacteria, Atypical, Influenza A Virus, H1N1 Subtype, Mycobacterium abscessus, Mycobacteria, Atypical

Reference

1.

1. World Health Organization. Influenza-like illness in the United States and Mexico [Internet]. Geneva: World Health Organization; c2010 [cited 2009 Apr 24]. Available from: http://www.who.int/csr/don/2009_04_24/en.

2.

2. World Health Organization. Pandemic (H1N1) 2009 -update 83 [Internet]. Geneva: World Organization; c2010 [cited 2010 Jan 15]. Available from: http://www.who.int/csr/don/2010_01_15/en.

3.

3. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2009;38 Suppl 4:e91-7.

4.

4. Kantzler GB, Lauteria SF, Cusumano CL, Lee JD,Ganguly R, Waldman RH. Immunosuppression during influenza virus infection. Infect Immun 1974;10:996-1002.

5.

5. Wallace RJ Jr. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.Eur J Clin Microbiol Infect Dis 1994;13:953-60.

6.

6. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC,Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-79.

7.

7. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria.An analysis of 154 patients. Am Rev Respir Dis 1993;147:1271-8.

8.

8. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr,Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993;16:463-71.

9.

9. Koh WJ, Kwon OJ, Ham HS, Suh GY, Chung MP, Kim HJ, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens. Korean J Med 2003;65:10-21.

10.

10. Collins CH, Grange JM, Yates MD. Mycobacteria in water. J Appl Bacteriol 1984;57:193-211.

11.

11. Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968;97:1032-7.

12.

12. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A,Daley C, Gordin F, et al. An official ATS/IDSA statement:diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.

13.

13. Koh WJ, Kwon OJ. Diagnosis and treatment of nontuberculous mycobacterial lung disease. Korean J Med 2008;74:120-31.

14.

14. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH,et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009;180:896-902.

15.

15. Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 2002;23:623-32, vii.

Tuberculosis & Respiratory Diseases